AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2072372 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium supplementation (64 mmol KCl)
Number of subjects: 24
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium intake (300 mmol per day)
Number of subjects: 25
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium intake (50-100 mmol per day)
Number of subjects: 25
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in plasma NE between HS and LS periods
Number of subjects: 25
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine release
Number of subjects: 25
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm blood flow (FBF)
Number of subjects: 25
Study 6519741 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in forearm vascular resistance
Number of subjects: 25
Study 30053212 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX) 1000 mg × 2 doses at 0, 15 days
Number of subjects: 60
Study 30053212 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CYC) 500 mg/m2 monthly
Number of subjects: 60
Study 30053212 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 60
Study 28557736 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools with increased opportunities for risk and challenge (e.g., rough-and-tumble play, reduced rules, added loose parts)
Number of subjects: 840
Study 28557736 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools with increased opportunities for risk and challenge
Number of subjects: 840
Study 28557736 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no change in play environment)
Number of subjects: 840
Study 26142924 — intervention group
Group type: EXPERIMENTAL
Intervention: Good-quality photodynamic diagnosis-assisted transurethral resection of bladder tumor (GQ-PDDTURBT)
Number of subjects: 808
Study 26142924 — intervention group
Group type: COMPARATOR
Intervention: Good-quality white-light transurethral resection of bladder tumor (GQ-WLTURBT)
Number of subjects: 808
Study 23912002 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20mg/day (E20)
Number of subjects: 0
Study 23912002 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 10mg/day (E10)
Number of subjects: 0
Study 23912002 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 10mg/day (O10)
Number of subjects: 0
Study 21114351 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy motivation (monetary incentives for accuracy)
Number of subjects: 0
Study 21114351 — intervention group
Group type: EXPERIMENTAL
Intervention: Provided anchors
Number of subjects: 0
Study 21114351 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generated anchors
Number of subjects: 0
Study 18395579 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 15183
Study 18395579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15183
Study 27812854 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc99m + blue dye (BD)
Number of subjects: 342
Study 27812854 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG)
Number of subjects: 342
Study 27812854 — intervention group
Group type: COMPARATOR
Intervention: SLN algorithm (SA)
Number of subjects: 342
Study 12839279 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg zinc daily for 5 days a week for 16 weeks
Number of subjects: 280
Study 11136297 — intervention group
Group type: COMPARATOR
Intervention: Loratadine alone
Number of subjects: 0
Study 11136297 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine + ketoconazole
Number of subjects: 0
Study 11136297 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine + cimetidine
Number of subjects: 0
Study 9135744 — intervention group
Group type: EXPERIMENTAL
Intervention: Displaced malleolar fractures (mean BMI 28.25 kg/m2)
Number of subjects: 0
Study 9135744 — intervention group
Group type: COMPARATOR
Intervention: Undisplaced malleolar fractures (mean BMI 24.58 kg/m2)
Number of subjects: 0
Study 1590373 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid study (infusion of lipid emulsion to meet resting energy requirements during 84‐h oral fast)
Number of subjects: 5
Study 1590373 — intervention group
Group type: COMPARATOR
Intervention: Control study (84 h fasting without lipid infusion)
Number of subjects: 5
Study 1590373 — intervention group
Group type: EXPERIMENTAL
Intervention: Both studies (control and lipid)
Number of subjects: 5
Study 6476319 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.6 mg intravenously
Number of subjects: 40
Study 6476319 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.2 mg intravenously
Number of subjects: 40
Study 31590219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal framing exercise-related pain as helpful
Number of subjects: 78
Study 31590219 — intervention group
Group type: COMPARATOR
Intervention: Cognitive reappraisal framing exercise-related pain as harmful
Number of subjects: 78
Study 29252842 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training combined with anodal electrode positioned over the primary motor cortex in the region of the dominant hemisphere and the cathode positioned in the supraorbital region contralateral to anode
Number of subjects: 30
Study 29252842 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training combined with the anodal electrode positioned over the primary motor cortex in the region of the injured hemisphere and the cathode positioned contralateral to anode over the primary motor cortex
Number of subjects: 30
Study 29252842 — intervention group
Group type: COMPARATOR
Intervention: Sham anodal transcranial direct current stimulation over the primary motor cortex and sham cathode over the contralateral supraorbital region combined with treadmill training
Number of subjects: 30
Study 26242728 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopy simulator system
Number of subjects: 50
Study 26242728 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopy simulator system
Number of subjects: 50
Study 24930546 — intervention group
Group type: EXPERIMENTAL
Intervention: MOM hip resurfacing system (ReCap)
Number of subjects: 52
Study 24930546 — intervention group
Group type: COMPARATOR
Intervention: Standard MOP total hip arthroplasty (Mallory Head/Exeter)
Number of subjects: 52
Study 21868372 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid supplementation
Number of subjects: 8
Study 21868372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 21109132 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (additional propofol 0.5 mg/kg)
Number of subjects: 102
Study 21109132 — intervention group
Group type: COMPARATOR
Intervention: Group A (1.5 mg/kg propofol)
Number of subjects: 102
Study 21109132 — intervention group
Group type: COMPARATOR
Intervention: Group C (2 mg/kg propofol)
Number of subjects: 102
Study 17236741 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based motivational intervention (20-minute single-session)
Number of subjects: 107
Study 17236741 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (Control group)
Number of subjects: 107
Study 17236741 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based motivational intervention
Number of subjects: 107
Study 15866550 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst-event challenge
Number of subjects: 335
Study 15866550 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance challenge
Number of subjects: 335
Study 15866550 — intervention group
Group type: EXPERIMENTAL
Intervention: Conduct problems (CP)
Number of subjects: 335
Study 15866550 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-challenge urinary epinephrine (E) levels
Number of subjects: 335
Study 15866550 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol concentrations in saliva
Number of subjects: 335
Study 12208409 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 40 mg/day
Number of subjects: 107
Study 12208409 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril 20 mg/day
Number of subjects: 107
Study 11477887 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RIFATER/4RIFINAH regimen
Number of subjects: 308
Study 11477887 — intervention group
Group type: COMPARATOR
Intervention: 2HRZ/4HR
Number of subjects: 308
Study 8594696 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg plus DEC 6mg/kg
Number of subjects: 1717
Study 8594696 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg alone
Number of subjects: 1717
Study 8594696 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC 6 mg/kg alone
Number of subjects: 1717
Study 8594696 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg plus DEC 3 mg/kg
Number of subjects: 1717
Study 8594696 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg
Number of subjects: 1717
Study 2706316 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg sustained-release methylphenidate (SR)
Number of subjects: 18
Study 2706316 — intervention group
Group type: COMPARATOR
Intervention: 10 mg immediate-release methylphenidate (IR)
Number of subjects: 18
Study 2706316 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of SR formulations
Number of subjects: 18
Study 770081 — intervention group
Group type: EXPERIMENTAL
Intervention: Azapropazone 1200 mg per day
Number of subjects: 41
Study 770081 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1600 mg per day
Number of subjects: 41
Study 770081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 770081 — intervention group
Group type: EXPERIMENTAL
Intervention: Azapropazone
Number of subjects: 41
Study 770081 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 41
Study 31976519 — intervention group
Group type: EXPERIMENTAL
Intervention: 11β‐MNTDC 200 mg daily
Number of subjects: 42
Study 31976519 — intervention group
Group type: EXPERIMENTAL
Intervention: 11β‐MNTDC 400 mg daily
Number of subjects: 42
Study 31976519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30642053 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan meal with tofu (V-meal)
Number of subjects: 60
Study 30642053 — intervention group
Group type: COMPARATOR
Intervention: Processed-meat and cheese meal (M-meal)
Number of subjects: 60
Study 28445600 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 72
Study 28445600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 24991883 — intervention group
Group type: COMPARATOR
Intervention: Infrared-C radiation hot compresses (IR-C HC)
Number of subjects: 0
Study 24991883 — intervention group
Group type: COMPARATOR
Intervention: Hot compresses (HC)
Number of subjects: 0
Study 24220538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance-based group therapy (MAGT)
Number of subjects: 137
Study 24220538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (CBGT)
Number of subjects: 137
Study 24220538 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 137
Study 21296441 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole breast radiotherapy using 3D dosimetry
Number of subjects: 279
Study 19717572 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports camp with six months of support from a local sports club
Number of subjects: 76
Study 19717572 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 76
Study 19717572 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 76
Study 17503982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Social Skills Training (CBSST)
Number of subjects: 76
Study 17503982 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 76
Study 16376251 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet release before wound closure
Number of subjects: 55
Study 16376251 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet release after wound closure
Number of subjects: 55
Study 11669483 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum group (sorbitol-sweetened chewing gum)
Number of subjects: 547
Study 11669483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gum)
Number of subjects: 547
Study 9842628 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular viewing conditions
Number of subjects: 30
Study 9842628 — intervention group
Group type: COMPARATOR
Intervention: Monocular viewing conditions
Number of subjects: 30
Study 9842628 — intervention group
Group type: EXPERIMENTAL
Intervention: Static environmental structure
Number of subjects: 30
Study 9842628 — intervention group
Group type: COMPARATOR
Intervention: Dynamic environmental structure
Number of subjects: 30
Study 8206771 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural‐sensory modeling video treatment
Number of subjects: 145
Study 8206771 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural modeling video treatment
Number of subjects: 145
Study 8206771 — intervention group
Group type: COMPARATOR
Intervention: Videotaped procedural modeling information
Number of subjects: 145
Study 8206771 — intervention group
Group type: COMPARATOR
Intervention: Videotaped procedural‐sensory modeling information
Number of subjects: 145
Study 8206771 — intervention group
Group type: COMPARATOR
Intervention: Procedural‐sensory information booklet
Number of subjects: 145
Study 8206771 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 145
Study 2913765 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 14
Study 2913765 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 14
Study 2913765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30121127 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 23
Study 30121127 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy (CLS)
Number of subjects: 23
Study 28063907 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard curriculum plus weekly video coaching by an expert laparoscopic surgeon
Number of subjects: 20
Study 28063907 — intervention group
Group type: COMPARATOR
Intervention: Standard simulation curriculum
Number of subjects: 20
Study 24496325 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial compression device (TR Band, Terumo Medical, Tokyo, Japan)
Number of subjects: 600
Study 24496325 — intervention group
Group type: COMPARATOR
Intervention: Chitosan‐based pad (Anscare, Daxon, Taoyuan, Taiwan)
Number of subjects: 600
Study 24460292 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Self-Examination (BSE)
Number of subjects: 52011
Study 24460292 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Breast Examination (CBE)
Number of subjects: 52011
Study 24460292 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for further investigations
Number of subjects: 52011
Study 22053537 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance training group (DTG; N = 60)
Number of subjects: 120
Study 22053537 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; N = 60)
Number of subjects: 120
Study 19196468 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine
Number of subjects: 90
Study 19196468 — intervention group
Group type: COMPARATOR
Intervention: Oral dihydrocodeine
Number of subjects: 90
Study 19196468 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up at 1, 3, and 6 months post detoxification
Number of subjects: 90
Study 16538135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% ophthalmic emulsion (Restasis) twice per day
Number of subjects: 17
Study 16538135 — intervention group
Group type: COMPARATOR
Intervention: Rewetting drops (carboxymethylcellulose 0.5%, Refresh Contacts) twice per day
Number of subjects: 17
Study 12639595 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence counseling
Number of subjects: 286
Study 12639595 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 286
Study 12639595 — intervention group
Group type: EXPERIMENTAL
Intervention: Grades
Number of subjects: 286
Study 12639595 — intervention group
Group type: EXPERIMENTAL
Intervention: Being bicultural
Number of subjects: 286
Study 12639595 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk behaviors
Number of subjects: 286
Study 12545629 — intervention group
Group type: COMPARATOR
Intervention: 10 cc of 2% lidocaine gel in the endorectal (group 1)
Number of subjects: 96
Study 12545629 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cc of 1% lidocaine solution injected into the apex (group 2)
Number of subjects: 96
Study 9798805 — intervention group
Group type: EXPERIMENTAL
Intervention: L plus clarithromycin (C) 250 mg b.d. plus tinidazole (T) 500 mg b.d. for 7 days (LCT)
Number of subjects: 112
Study 9798805 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC plus C 250 mg b.d. and T 500 mg b.d. for 7 days (RbcCT)
Number of subjects: 112
Study 9798805 — intervention group
Group type: COMPARATOR
Intervention: LCT and RbcCT
Number of subjects: 112
Study 7617820 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/70 kg intravenous diphenhydramine
Number of subjects: 10
Study 7617820 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study 2144153 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrantectomy plus external radiotherapy
Number of subjects: 705
Study 2144153 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy plus external and interstitial radiotherapy
Number of subjects: 705
Study 667190 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate feedback of skin resistance level changes
Number of subjects: 36
Study 667190 — intervention group
Group type: COMPARATOR
Intervention: Inaccurate feedback of skin resistance level changes
Number of subjects: 36
Study 30548529 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Catheter Removal (ICR)
Number of subjects: 155
Study 30548529 — intervention group
Group type: COMPARATOR
Intervention: Delayed Catheter Removal (DCR)
Number of subjects: 155
Study 28245280 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention delivered by community health workers (16 home visits from third trimester to 6 months postpartum)
Number of subjects: 220
Study 28245280 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention for short allele carriers
Number of subjects: 220
Study 28245280 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention for long allele carriers
Number of subjects: 220
Study 28245280 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with short allele
Number of subjects: 220
Study 28245280 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with long allele
Number of subjects: 220
Study 25381468 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofix(®) arrows
Number of subjects: 46
Study 25381468 — intervention group
Group type: COMPARATOR
Intervention: FasT‐Fix(®) suture devices
Number of subjects: 46
Study 25381468 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 46
Study 25381468 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperated patients
Number of subjects: 46
Study 23237788 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (1600 mg EGCG and 600 mg caffeine)
Number of subjects: 8
Study 23237788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 21815857 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic Stepping Exercise (RSE)
Number of subjects: 52
Study 21815857 — intervention group
Group type: COMPARATOR
Intervention: Non-Rhythmic Stepping Exercise (NRSE)
Number of subjects: 52
Study 19363633 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral deep brain stimulation (DBS) in globus pallidus (GPi)
Number of subjects: 42
Study 19363633 — intervention group
Group type: COMPARATOR
Intervention: Unilateral deep brain stimulation (DBS) in subthalamic nucleus (STN)
Number of subjects: 42
Study 16460562 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (500 micrograms twice daily)
Number of subjects: 250
Study 16460562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol combination (500/50 micrograms twice daily)
Number of subjects: 250
Study 16460562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 15851196 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 4450
Study 15851196 — intervention group
Group type: COMPARATOR
Intervention: No ICD therapy
Number of subjects: 4450
Study 15851196 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal variation in mortality
Number of subjects: 4450
Study 15851196 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk season variable (spring in the north and winter in the south)
Number of subjects: 4450
Study 11782265 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization training combined with dynamic resistance training (group 2, n=20)
Number of subjects: 59
Study 11782265 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization training combined with dynamic‐static resistance training (group 3, n=20)
Number of subjects: 59
Study 11782265 — intervention group
Group type: COMPARATOR
Intervention: Stabilization training (group 1, n=19)
Number of subjects: 59
Study 9265916 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine 10 mg/day
Number of subjects: 0
Study 9265916 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 0
Study 9265916 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 8497434 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg twice daily
Number of subjects: 24
Study 8497434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily
Number of subjects: 24
Study 8497434 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox 600 mg twice daily
Number of subjects: 24
Study 30379302 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (multicomponent intervention program)
Number of subjects: 290